Indaptus Therapeutics Inc
Change company Symbol lookup
Select an option...
INDP Indaptus Therapeutics Inc
T AT&T Inc
AMAOU American Acquisition Opportunity Inc
VTI Vanguard Total Stock Market Index Fund ETF Shares
DSEY Diversey Holdings Ltd
LGIH LGI Homes Inc
CRZNU Corazon Capital V838 Monoceros Corp
PCG-I Pacific Gas and Electric Co
ASZ Austerlitz Acquisition II Corp
$NQEG60CAD Nasdaq Egypt Energy Price Return CAD
Go

Company profile

Indaptus Therapeutics, Inc, formerly Intec Parent, Inc, offers immunotherapy to cure diseases. The Company is engaged in developing pre-clinical pipeline of therapeutic candidates to produce anti-tumor and anti-viral responses and cure diseases. It designs its approach by targeting specific tumor or viral antigens. Its lead candidate, Decoy20, is in pre-clinical development. Its platform is based on the hypothesis that require anti-tumor immunotherapy to activate both innate and adaptive cellular immunity in both tumors and immune organs. Its approach uses multi-targeted package of bacterial pathogen-associated molecular patterns (PAMPs) in the form of attenuated and killed, intact but non-pathogenic bacteria delivered intravenously. Its intravenous therapeutic candidates target the liver, spleen, and leaky vasculature of tumors, producing immune activation in an immune organ, as well as a common site for primary and metastatic cancer and hepatitis B virus (HBV) infection.

Postmarket

Last Trade
Delayed
$8.30
-0.12 (-1.43%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$8.42
Day's Change
0.15 (1.81%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
9.25
Day's Low
7.93
Volume
(Light)
Volume:
2,810,878

10-day average volume:
21,693,933
2,810,878
  • Prev Close
    8.27
  • Today's Open
    8.27
  • Day's Range
    7.93-9.25
  • Avg Vol (10-day)
    21.7M
  • Last (time)
    4:00p ET 09/22/21
  • Last (size)
    32
  • 52-Wk Range
    6.84 - 36.80
    LowHigh
  • (02/11/21 - 09/14/21)
    23.10%
  • 130.7%
  • Market Cap
    45.5M
  • Shares Outstanding
    5.4M
  • -16.40
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.2
  • 4.19
  • (% of float 08/31/21)
    11.17

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.